XFOR

X4 Pharmaceuticals Inc. is a Boston-based clinical-stage biopharmaceutical company dedicated to developing innovative therapies for rare and serious diseases, particularly in back disorders. Leveraging its proprietary technology, the company is advancing a robust pipeline of investigational therapies designed to address significant unmet medical needs and improve patient outcomes. As X4 progresses through various clinical development phases, it embodies a strong potential for growth and impact within the biopharmaceutical sector, positioning itself as a key player in the evolving landscape of therapeutic solutions.